Concord Wealth Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19
Closed -$715 891
2023
Q4
$715 Hold
19
﹤0.01% 771
2023
Q3
$856 Hold
19
﹤0.01% 955
2023
Q2
$1.4K Hold
19
﹤0.01% 912
2023
Q1
$1.11K Hold
19
﹤0.01% 885
2022
Q4
$958 Buy
+19
New +$1.14K ﹤0.01% 1067
2022
Q3
Sell
-19
Closed -$2K 814
2022
Q2
$2K Hold
19
﹤0.01% 1041
2022
Q1
$2K Hold
19
﹤0.01% 1120
2021
Q4
$3K Hold
19
﹤0.01% 1071
2021
Q3
$3K Hold
19
﹤0.01% 701
2021
Q2
$3K Hold
19
﹤0.01% 835
2021
Q1
$2K Hold
19
﹤0.01% 843
2020
Q4
$2K Buy
+19
New +$1.86K ﹤0.01% 553

Other funds holding OMCL

Concord Wealth Partners's OMCL Position: Q1 2024 in Review

Concord Wealth Partners sold out of Omnicell (OMCL) in Q1 2024, closing a stake of 19 shares — an estimated $715 sold.

Concord Wealth Partners first reported a position in OMCL in Q4 2020 and held it in 12 quarters. The position peaked at $3K in Q4 2021. 266 funds tracked by Wall St. Rank hold OMCL as of Q1 2024.

  • Concord Wealth Partners reported no remaining Omnicell position as of Q1 2024 after selling out during the quarter.
  • Concord Wealth Partners sold 19 Omnicell shares in Q1 2024, an estimated $715.
  • Concord Wealth Partners first reported a position in Omnicell in Q4 2020 and held it in 12 quarters.
  • Concord Wealth Partners's Omnicell position peaked at $3K in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Omnicell as of Q1 2024.

Based on Concord Wealth Partners's 13F filing for Q1 2024, filed 30 Apr 2024.